Fig. 3From: HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patientsCombined predictive value of changes of HbsAg, HBeAg, and HBV DNA at weeks 12 and 24 for SR and CR at week 72 (end of follow-up, EOF). SR, sustained response; CR, combined responseBack to article page